Login / Signup

Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database.

Lusha CaoYuan-Shung V HuangChao WuKelly GetzTamara P MillerJenny RuizBrian T FisherAlix E SeifRichard AplencYimei Li
Published in: Pediatric blood & cancer (2023)
A carefully designed ML model can accurately identify pediatric AML patients and their chemotherapy courses from administrative databases. This approach may be generalizable to other diseases and databases.
Keyphrases
  • acute myeloid leukemia
  • end stage renal disease
  • machine learning
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • big data
  • emergency department
  • artificial intelligence
  • patient reported